Responses of intraocular pressure and the pupil of feline eyes to prostaglandin and EP1 and FP1 receptor agonists

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 12, 1999, Pages 3047-3053

  Bhattacherjee, Parimal ^a,b   Williams, Billy Shawn ^a   Paterson, Christopher A ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 ACETYL 2 (8 CHLORO 10,11 DIHYDRODIBENZ[B,F][1,4]OXAZEPINE 10 CARBONYL)HYDRAZINE; 3 BENZYL 5 (6 CARBOXYHEXYL) 1 (2 CYCLOHEXYL 2 HYDROXYETHYLAMINO)HYDANTOIN; 7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; FLUPROSTENOL; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN F; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; SC 51089; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CAT; CILIARY MUSCLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG POTENCY; INTRAOCULAR PRESSURE; MUSCLE RELAXATION; NONHUMAN; PRIORITY JOURNAL; PUPIL; TOPICAL DRUG ADMINISTRATION;

ANIMALS; CATS; DINOPROST; DOSE-RESPONSE RELATIONSHIP, DRUG; INTRAOCULAR PRESSURE; PROSTAGLANDIN ANTAGONISTS; PROSTAGLANDINS F, SYNTHETIC; PUPIL; RANDOM ALLOCATION; RECEPTORS, PROSTAGLANDIN; RECEPTORS, PROSTAGLANDIN E; TONOMETRY, OCULAR;

EID: 0032712665     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Camras CB, Bito LZ, Eakins KE. Reduction of intraocular pressure by prostaglandins applied topically to the eyes of conscious rabbits. Invest Ophthalmol Vis Sci. 1977;16:1125-1134.
2. Bito LZ, Camras CB, Gum GG, Resul B. The ocular hypotensive effects and side effects of prostaglandins on the eyes of experimental animals. In: Bito LZ, Stjernschantz J, eds. The Ocular Effects of Prostaglandins and Other Eicosanoids. New York: Alan R. Liss; 1989:349-368.
3. 2α and its isopropyl ester on normal and glaucomatous human eyes. In: Bito LZ, Stjernschantz J, eds. The Ocular Effects of Prostaglandins and Other Eicosanoids. New York: Alan R. Liss; 1989:447-458.
4. 2α analog: effect on intraocular pressure in patients with ocular hypertension. Br J Ophthalmol. 1992;76:214-217.
5. 2α increases uveoscleral outflow in the cynomolgus monkey. Exp Eye Res. 1989;49:389-402.
6. 2α. Arch Ophthalmol. 1987;105:1112-1116.
7. 2α on calcium efflux. Invest Ophthalmol Vis Sci. 1992;33:2679-2686.
8. 2 and FP receptors in human ciliary epithelial and ciliary muscle cells. Biochem Pharmacol. 1997;53: 1249-1255.
9. Chen W, Bhattacherjee P, Paterson CA. Mobilization of intracellular calcium by prostaglandins in human ciliary muscle cells and NIH 3T3 cell line. Invest Ophthalmol Vis Sci. 1996;37(3):S838. Abstract nr 3867.
10. Chen W, Andom T, Bhattacherjee P, Paterson CA. Intracellular calcium mobilization following prostaglandin receptor activation in human ciliary muscle cells. Curr Eye Res. 1997;16:847-853.
11. 2α effects on intraocular pressure negatively correlate with FP-receptor stimulation. Invest Ophthalmol Vis Sci. 1989;30:1838-1842.
12. 2 and DP receptors. Invest Ophthalmol Vis Sci 1992;33:3195-3201.
13. Goh Y, Hotechama Y, Mishima HK. Characterization of ciliary muscle relaxation induced by various agents in cats. Invest Ophthalmol Vis Sci. 1995;30:1188-1192.
14. Bhattacherjee P, Smithson M, Paterson CA. Generation of second messengers by prostanoids in the iris-sphincter and ciliary muscles of cows, cats, and humans. Prostaglandins Leukot Essent Fatty Acids. 1997;56:443-449.
15. Zhan G, Miranda OC, Bito LZ. Steroid glaucoma: corticosteroid-induced ocular hypertension in cats. Exp Eye Res. 1992;54:211-218.
16. 2 increases uveoscleral outflow and trabecular outflow facility in the cat. Exp Eye Res. 1995;61:649-657.
17. Bhattacherjee P, Williams BS, Paterson CP, Spellman JM, Graf G, Yanni JM. Pharmacological validation of a feline model of steroid-induced ocular hypertension. Arch Ophthalmol. 1999;117:361-364.
18. Bito LZ, Miranda OC, Tendler MR, Resul B. Eicosanoids as a new class of ocular hypotensive agents, 3: prostaglandin A2-1-isopropyl ester is the most potent reported hypotensive agent on feline eyes. Exp Eye Res. 1989;50:419-428.
19. 2α on cat and rhesus monkey eyes. Invest Ophthalmol Vis Sci. 1982;22:588-598.
20. Alexander SPH, Peters JA. Receptor and ion channel nomenclature. Trends in Pharmacological Sciences (Supplement). Cambridge, UK: Elsevier Trend Journals; 1998.
21. Coleman RA, Kennedy I, Humphrey PA, Bunce K, Lumley P. Prostanoids and their receptors. In: Emmet JC, ed. Comprehensive Medicinal Chemistry. Oxford, UK: Pergamon Press; 1990;3:643-714.
22. 2 and its analogues on intraocular pressure in rabbits. Jpn J Ophthalmol. 1988;32:471-480.
23. 2, FP, or TP, prostanoid-receptor stimulation may reduce intraocular pressure. Invest Ophthalmol Vis Sci. 1990;31:2560-2567.
24. 2-mimetic with ocular hypotensive properties. J Ocul Pharmacol Ther. 1995;11:203-212.
25. Giles H, Leff P, Bolofo ML, Kelly MG, Robertson AD. The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist. Br J Pharmacol. 1989;96:291-300.
26. Ogletree ML, Allen GT. Interspecies differences in thromboxane receptors: studies with thromboxane receptor antagonists in rat and guinea-pig smooth muscles. J Pharmacol Exp Ther. 1992;260: 789-794.
27. Grass GM, Robinson JR. Mechanisms of corneal drug penetration: in vivo and in vitro kinetics. J Pharm Sci. 1988;77:3-14.
28. Grass GM, Robinson JR. Relationship of chemical structure to corneal penetration and influence of low-viscosity solution on ocular bioavailability. J Pharm Sci. 1984;73:1021-1027.
29. Hui HW, Zeleznick L, Robinson JR. Ocular disposition of topically applied histamine, cimetidine, and pyrilamine in the albino rabbit. Curr Eye Res. 1984;3:321-330.
30. Krauss A, Woodward D, Burk TS, et al. Pharmacological evidence for thromboxane receptor heterogeneity-implications for the eye. J Ocul Pharmacol Ther. 1997;13:303-312.